StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) operating KPIs

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)

Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%

AbbVie product Quality — External Regulatory Inspections of Commercial Manufacturing (inspections)

AbbVie ESG Action Reports & Form SD

Latest, FY2025
55
Period ended Dec 31, 2025
Change on a year earlier
-8.3%
60 in FY2024
History
5 years
Since FY2021
Sources
2
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedProduct Quality — External Regulatory Inspections of Commercial Manufacturing (inspections)Year on yearSource
FY2025Dec 31, 202555-8.3%AbbVie 2025 ESG Action Report ↗
FY2024Dec 31, 202460+9.1%AbbVie 2025 ESG Action Report ↗
FY2023Dec 31, 202355+22.2%AbbVie 2025 ESG Action Report ↗
FY2022Dec 31, 202245-21.1%AbbVie 2023 ESG Action Report ↗
FY2021Dec 31, 202157–AbbVie 2023 ESG Action Report ↗

Breakdown

What makes up product quality — external regulatory inspections of commercial manufacturing (inspections)

Cite this data

StockData. (2026). AbbVie Product Quality — External Regulatory Inspections of Commercial Manufacturing (inspections), annual FY2021–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/esg_ext_inspections

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.